Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Rouleau

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Cancer Research|June 1, 1995
The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cellsM Lutchman, G A Rouleau
Trends in Neurosciences|September 1, 1996
Neurofibromatosis type 2: a new mechanism of tumor suppressionM Lutchman, G A Rouleau
Neurobiology of Disease|March 10, 2009
Molecular mechanisms underlying polyalanine diseasesC Messaed, G A Rouleau
Cancer Detection and Prevention|January 1, 1994
Genetics, prognosis and therapy of central nervous system tumorsD Watkins, G A Rouleau
Revue Neurologique|January 1, 1992
Oncogenes and glial tumorsD Watkins, G A Rouleau
Genetic Epidemiology|December 22, 1999
Family density of alcoholism and linkage information in the analysis of the COGA dataG Turecki, G A Rouleau, M Alda
Neuroreport|October 2, 1995
Widespread but cell type-specific expression of the mouse neurofibromatosis type 2 geneJ O Claudio, M Lutchman, G A Rouleau
Human Molecular Genetics|January 1, 1994
The mouse homologue of the neurofibromatosis type 2 gene is highly conservedJ O Claudio, C Marineau, G A Rouleau
Genomics|May 1, 1994
Evidence for the existence of a fourth dominantly inherited spinocerebellar ataxia locusI Lopes-Cendes, E Andermann, G A Rouleau
Genomics|May 15, 1994
The mouse neurofibromatosis type 2 gene maps to chromosome 11J O Claudio, D Malo, G A Rouleau
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Cancer Research|June 1, 1995
The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cellsM Lutchman, G A Rouleau
Trends in Neurosciences|September 1, 1996
Neurofibromatosis type 2: a new mechanism of tumor suppressionM Lutchman, G A Rouleau
Neurobiology of Disease|March 10, 2009
Molecular mechanisms underlying polyalanine diseasesC Messaed, G A Rouleau
Cancer Detection and Prevention|January 1, 1994
Genetics, prognosis and therapy of central nervous system tumorsD Watkins, G A Rouleau
Revue Neurologique|January 1, 1992
Oncogenes and glial tumorsD Watkins, G A Rouleau
Genetic Epidemiology|December 22, 1999
Family density of alcoholism and linkage information in the analysis of the COGA dataG Turecki, G A Rouleau, M Alda
Neuroreport|October 2, 1995
Widespread but cell type-specific expression of the mouse neurofibromatosis type 2 geneJ O Claudio, M Lutchman, G A Rouleau
Human Molecular Genetics|January 1, 1994
The mouse homologue of the neurofibromatosis type 2 gene is highly conservedJ O Claudio, C Marineau, G A Rouleau
Genomics|May 1, 1994
Evidence for the existence of a fourth dominantly inherited spinocerebellar ataxia locusI Lopes-Cendes, E Andermann, G A Rouleau
Genomics|May 15, 1994
The mouse neurofibromatosis type 2 gene maps to chromosome 11J O Claudio, D Malo, G A Rouleau
Pageof 21